Stock Taper
OPPORTUNITY RADAR
SCREENER
COMPARE ANY 2 STOCKS
Pricing
Log In
SIGN UP
EARNINGS CALL ARCHIVE
2 CALLS ON FILE
EW
— Edwards Lifesciences Corporation
NYSE
FULL STOCK PAGE →
Q4 2025 Earnings Call Summary
FEB 10, 2026
REVENUE
$1.57B
+1.1%
NET MARGIN
5.8%
-12.9 PTS
EPS
$0.16
-68.0%
FREE CASH FLOW
$353.5M
-31.5%
No summary has been written for this call yet.
← NEWER CALL
CALL 1 OF 2
OLDER CALL →